Atlas Trials

WeiShi

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch WeiShi

RecordFirmDate
Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT. (NCT07569653)WeiShi2025-10-30
A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT (NCT07606703)WeiShi2025-09-01

Track WeiShi automatically

Every clearance here is in the API, with alerts when new ones post.